A Prospective, Multicenter, Randomized, Open-label Trial to Compare Efficacy and Safety of Clopidogrel vs Ticagrelor in Stabilized Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention; TicAgrelor Versus CLOpidogrel in Stabilized Patients With Acute Myocardial Infarction: TALOS-AMI
Phase of Trial: Phase IV
Latest Information Update: 04 May 2017
Price : $35 *
At a glance
- Drugs Clopidogrel (Primary) ; Ticagrelor (Primary)
- Indications Myocardial infarction; Thrombosis
- Focus Therapeutic Use
- Acronyms TALOS-AMI
- 01 Jun 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Dec 2016 as per ClinicalTrials.gov record.
- 17 Jun 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 14 Jan 2014 New trial record